Correct. Net debt is $20M with the rest being available if required. This is from the latest results release:
"Net debt was $19.9 million at the end of the period, with available liquidity of
$400 million"
Debt refinancing is also planned with the current facility not due until August 2019 so plenty of time to get this sorted. This is also a chance to get some more legroom on the covenants though borrowing costs might go up as a result. Low risk of Myer going under in the short term IMO, hence why my sentiment is a buy for short term.
- Forums
- ASX - By Stock
- MYR
- Ann: Myer Half Year Results (1H2018)
Ann: Myer Half Year Results (1H2018), page-126
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYR (ASX) to my watchlist
|
|||||
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $665.4M |
Open | High | Low | Value | Volume |
80.0¢ | 80.5¢ | 79.5¢ | $443.6K | 553.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 38305 | 80.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.5¢ | 101283 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 40505 | 0.800 |
9 | 27053 | 0.795 |
11 | 46685 | 0.790 |
10 | 113542 | 0.785 |
7 | 10336 | 0.780 |
Price($) | Vol. | No. |
---|---|---|
0.805 | 101283 | 6 |
0.810 | 44401 | 5 |
0.815 | 73688 | 7 |
0.820 | 115617 | 16 |
0.825 | 52762 | 4 |
Last trade - 11.05am 16/07/2024 (20 minute delay) ? |
Featured News
MYR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online